Belite Bio (BLTE) Return on Equity [ROE] (2023 - 2026)
Belite Bio's Return on Equity [ROE] came in at -9.78% for Q2 2026, up 15.58 percentage points from -25.36% a year earlier but down 1.52 percentage points from the prior quarter.
Powered by 
Analysis
Belite Bio (BLTE) Return on Equity [ROE] (2023 - 2026) Analysis & Trends
For FY2025, Belite Bio's Return on Equity [ROE] was -16.91%, up 13.93 percentage points from FY2024.
- Return on Equity [ROE] has increased in each of the last three years, with a three-year change of +80.36 percentage points (FY2022 to FY2025).
- Going back by year, Return on Equity [ROE] was -30.84% in FY2024 (+17.08 pp), -47.92% in FY2023 (+49.35 pp) and -97.27% in FY2022.
- The five-year range for quarterly Return on Equity [ROE] is -48.72% (Q1 2023) to -8.26% (Q1 2026).
- Year-over-year, Return on Equity [ROE] has increased for ten consecutive quarters, with an average year-over-year change of +11.03 percentage points over the last eight quarters.
- Over the past five years, the year-over-year gain in Return on Equity [ROE] ranged from 1.97 percentage points (Q2 2024) to 21.10 percentage points (Q1 2024).
- Business Quant data shows BLTE's Return on Equity [ROE] at -8.26% (Q1 2026), -9.97% (Q4 2025) and -24.56% (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 74.39% |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 19.33% |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | - |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 5.63% |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 21.60% |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 72.13% |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | -31.17% |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 4.66% |
| 10 | Belite Bio | 6.16 Bn | 6.16 Bn | - | -13.02% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -13.02% |
| Mar 31, 2026 | -11.51% |
| Dec 31, 2025 | -14.84% |
| Sep 30, 2025 | -29.44% |
| Jun 30, 2025 | -32.09% |
| Mar 31, 2025 | -28.12% |
| Dec 31, 2024 | -28.24% |
| Sep 30, 2024 | -29.04% |
| Jun 30, 2024 | -33.47% |
| Mar 31, 2024 | -34.99% |
| Dec 31, 2023 | -44.15% |
| Sep 30, 2023 | -57.90% |
| Jun 30, 2023 | -50.60% |
| Mar 31, 2023 | -48.72% |
API Access
Belite Bio Return on Equity [ROE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=BLTE&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-equity-[roe]", "ticker": "BLTE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=BLTE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();